FDA Inspection
Weckerle Cosmetics USA, INCWeckerle Cosmetics USA, INC – FDA Inspection, Oct 31, 2025
Record Details
This FDA Inspection record concerns Weckerle Cosmetics USA, INC, with an inspection on October 31, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 1bcc4cd4-945c-49e2-b275-51164fb46594
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1291962
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.170(a)Active ingredient retained sample kept
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Weckerle Cosmetics USA, INC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 12, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Weckerle Cosmetics USA, INC
- FDA Inspection 1137445 - 2021-03-26
- FDA Inspection 949084 - 2015-11-17
- FDA Inspection 803187 - 2012-10-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.